• about
  • DC IMMUNOTHERAPY
    • THE PRINCIPLE
    • ABOUT MESOPHER
    • PUBLICATIONS
  • pipeline
    • PLEURAL MESOTHELIOMA
    • PERITONEAL MESOTHELIOMA
    • PANCREATIC CANCER
  • partners & investors
  • news
  • contact
  1. Home
  2. Amphera news
  3. EMA Orphan Designation granted

EMA Orphan Designation granted

09 Apr 2014

The European Commission granted orphan designation (EU/3/13/1229, 16 January 2014) to Amphera for her innovative immunotherapy for the treatment of malignant mesothelioma.

Previous Amphera is awarded first Red MedTechVentures loan of 350.000 Euro
Next FDA Orphan Designation granted
  • disclaimer
  • privacy policy

© 2019 Scicomvisuals, all rights reserved.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok